JP2021523744A5 - - Google Patents
Info
- Publication number
- JP2021523744A5 JP2021523744A5 JP2021514483A JP2021514483A JP2021523744A5 JP 2021523744 A5 JP2021523744 A5 JP 2021523744A5 JP 2021514483 A JP2021514483 A JP 2021514483A JP 2021514483 A JP2021514483 A JP 2021514483A JP 2021523744 A5 JP2021523744 A5 JP 2021523744A5
- Authority
- JP
- Japan
- Prior art keywords
- signature
- expression levels
- stroke
- biomarkers
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024051056A JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305600.1 | 2018-05-16 | ||
| EP18305600 | 2018-05-16 | ||
| PCT/EP2019/062653 WO2019219831A1 (en) | 2018-05-16 | 2019-05-16 | Blood biomarkers of stroke |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024051056A Division JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523744A JP2021523744A (ja) | 2021-09-09 |
| JP2021523744A5 true JP2021523744A5 (enExample) | 2022-05-23 |
| JP7463351B2 JP7463351B2 (ja) | 2024-04-08 |
Family
ID=62386311
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514483A Active JP7463351B2 (ja) | 2018-05-16 | 2019-05-16 | 脳卒中の血液バイオマーカー |
| JP2024051056A Pending JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024051056A Pending JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12247257B2 (enExample) |
| EP (1) | EP3794355A1 (enExample) |
| JP (2) | JP7463351B2 (enExample) |
| KR (1) | KR20210049026A (enExample) |
| CN (1) | CN112424609A (enExample) |
| AU (1) | AU2019270404B2 (enExample) |
| BR (1) | BR112020023259A2 (enExample) |
| CA (1) | CA3100171A1 (enExample) |
| IL (1) | IL278666B2 (enExample) |
| MA (1) | MA52617A (enExample) |
| MX (1) | MX2020012297A (enExample) |
| SG (1) | SG11202011369VA (enExample) |
| WO (1) | WO2019219831A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220093267A1 (en) * | 2019-01-22 | 2022-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Noninvasive real-time patient-specific assessment of stroke severity |
| CN114107487B (zh) * | 2021-12-23 | 2024-01-09 | 太原市精神病医院 | 一种可用于诊断脑卒中的产品 |
| JP7861981B2 (ja) * | 2022-01-31 | 2026-05-19 | 国立研究開発法人国立循環器病研究センター | 再灌流療法の適用を決定するバイオマーカー |
| CN116705296B (zh) * | 2023-06-06 | 2024-09-13 | 中国科学院深圳先进技术研究院 | 一种基于常规mri序列对gbm患者进行风险分层的方法及系统 |
| CN117925813A (zh) * | 2023-11-27 | 2024-04-26 | 中国医学科学院药用植物研究所 | 缺血性卒中诊断模型和抗血小板药物的筛选方法 |
| WO2025151599A1 (en) * | 2024-01-09 | 2025-07-17 | Morehouse School Of Medicine | Rna-based method for stroke assessment and treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| WO2003008647A2 (en) * | 2000-11-28 | 2003-01-30 | University Of Cincinnati | Blood assessment of injury |
| US9005891B2 (en) | 2009-11-10 | 2015-04-14 | Genomic Health, Inc. | Methods for depleting RNA from nucleic acid samples |
| US9410204B2 (en) | 2012-01-07 | 2016-08-09 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
| US20150274815A1 (en) * | 2012-09-25 | 2015-10-01 | The United States of America, as represented by the Secretary, Department of Health & Human Servic | Treatment of central nervous system (cns) injury |
| EP2951318A4 (en) | 2013-02-01 | 2016-08-17 | Univ West Virginia | BIOMARKER ALGORITHM FOR DETERMINING THE TIME OF INSERTING A STROKE SYMPTOM AND METHOD |
| WO2015054700A2 (en) * | 2013-10-13 | 2015-04-16 | The Research Foundation For Suny | Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof |
| GB2556004A (en) | 2015-07-10 | 2018-05-16 | Univ West Virginia | Markers of stroke and stroke severity |
| US20190311789A1 (en) * | 2016-10-03 | 2019-10-10 | West Virginia University | Computer implemented discovery of biomarkers for blood brain barrier disruption |
-
2019
- 2019-05-16 BR BR112020023259-9A patent/BR112020023259A2/pt unknown
- 2019-05-16 US US17/054,820 patent/US12247257B2/en active Active
- 2019-05-16 AU AU2019270404A patent/AU2019270404B2/en active Active
- 2019-05-16 CN CN201980047566.0A patent/CN112424609A/zh active Pending
- 2019-05-16 CA CA3100171A patent/CA3100171A1/en active Pending
- 2019-05-16 WO PCT/EP2019/062653 patent/WO2019219831A1/en not_active Ceased
- 2019-05-16 JP JP2021514483A patent/JP7463351B2/ja active Active
- 2019-05-16 KR KR1020207035973A patent/KR20210049026A/ko not_active Ceased
- 2019-05-16 MA MA052617A patent/MA52617A/fr unknown
- 2019-05-16 MX MX2020012297A patent/MX2020012297A/es unknown
- 2019-05-16 IL IL278666A patent/IL278666B2/en unknown
- 2019-05-16 EP EP19723441.2A patent/EP3794355A1/en active Pending
- 2019-05-16 SG SG11202011369VA patent/SG11202011369VA/en unknown
-
2024
- 2024-03-27 JP JP2024051056A patent/JP2024075761A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278666B2 (en) | Blood biomarkers of stroke | |
| Robertson et al. | Risk stratification in acute variceal bleeding: Comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding | |
| Christ‐Crain et al. | Use of B‐type natriuretic peptide in the risk stratification of community‐acquired pneumonia | |
| Schwabl et al. | Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease | |
| Zheng et al. | Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension | |
| RU2016137685A (ru) | Способ диагностики туберкулеза | |
| Pronschinske et al. | Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement | |
| Taneja et al. | Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver | |
| RAHIMI et al. | Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions | |
| Sinha et al. | Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach | |
| Bustamante et al. | Sepsis biomarkers reprofiling to predict stroke-associated infections | |
| JP2021523379A5 (enExample) | ||
| JP2020514689A5 (enExample) | ||
| RU2019103403A (ru) | Адреномедуллин для оценки застоя у индивидуума с острой сердечной недостаточностью | |
| Sawicki et al. | Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes | |
| Langsford et al. | The association between biomarker profiles, etiology of chronic kidney disease, and mortality | |
| Maznyczka et al. | Troponins and other biomarkers in the early diagnosis of acute myocardial infarction | |
| Bonanad et al. | Serum heat shock protein 60 in acute heart failure: a new biomarker? | |
| Nishikawa et al. | Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein in chronic hepatitis C | |
| Barba et al. | Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation | |
| WANG et al. | Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis | |
| Lim et al. | Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women | |
| ES2977423T3 (es) | Angiopoyetina-2 (Ang-2) circulante y proteína de unión al factor de crecimiento insulínico 7 (IGFBP7) para la predicción de apoplejía | |
| Kube et al. | The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure | |
| Ruenwilai et al. | Circulating Biomarkers for Predicting Disease Progression in Idiopathic Pulmonary Fibrosis: Insights into Precision Medicine |